Trial NCT04369742
Publication Ulrich RJ, Open Forum Infect Di, 2020
Primary outcome on the report: Proportion of subjects meeting a severe COVID-19 progression composite endpoint (death, ICU admission, mechanical ventilation, ECMO, and/or vasopressor use) at day 14; Cumulative incidence of serious adverse events, grade 3 or 4 adverse events, and/o